S
Susanne Muehlschlegel
Researcher at University of Massachusetts Medical School
Publications - 75
Citations - 1502
Susanne Muehlschlegel is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Medicine & Neurointensive care. The author has an hindex of 20, co-authored 55 publications receiving 994 citations. Previous affiliations of Susanne Muehlschlegel include Brigham and Women's Hospital & Harvard University.
Papers
More filters
Journal ArticleDOI
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.
Magdy Selim,Magdy Selim,Lydia D. Foster,Claudia S. Moy,Guohua Xi,Michael D. Hill,Lewis B. Morgenstern,Steven M. Greenberg,Michael L. James,Vineeta Singh,Wayne M. Clark,Casey Norton,Yuko Y. Palesch,Sharon D. Yeatts,Monica Dolan,Erlinda Yeh,Kevin N. Sheth,Kimberly Kunze,Susanne Muehlschlegel,Iryna Nieto,Jan Claassen,Cristina Falo,David Huang,Anne Beckwith,Steven R. Messé,Melissa Yates,Kristine O'Phelan,Andrea Escobar,Kyra J. Becker,Patricia Tanzi,Nicole R. Gonzales,Chad Tremont,Chitra Venkatasubramanian,Rosita Thiessen,Supriya Save,Steven Verrault,Karin Collard,Michael DeGeorgia,Valerie Cwiklinski,Bradford B Thompson,Lesley Wasilewski,Charles M. Andrews,Robert Burfeind,Michel T. Torbey,Mohammad Hamed,Kenneth Butcher,Leka Sivakumar,Nicolaou Varelas,Kathleen Mays-Wilson,Enrique C. Leira,Heena Olalde,Scott Silliman,Rhonda Calhoun,Neha S. Dangayach,Ricardo Renvill,Rishi Malhotra,Kristina Kordesch,Aaron Lord,Thomas Calahan,Romergryko G. Geocadin,Michelle Parish,James L. Frey,Mary Harrigan,Dana Leifer,Ryna Mathias,Michael J. Schneck,Tara Bernier,Sergio Gonzales-Arias,Josette Elysee,George A. Lopez,Josephine Volgi,Robert H. Brown,Sara Jasak,Stephen J. Phillips,Judith Jarrett,Joao Gomes,Moneen McBride,Francois Aldrich,Charlene Aldrich,Joshua Kornbluth,Michelle Bettle,Joshua N. Goldstein,Gregory Tirrell,Qaisar Shaw,Karin Jonczak +84 more
TL;DR: The primary result showed that further study of the efficacy of deferoxamine mesylate with anticipation that the drug would significantly improve the chance of good clinical outcome would be futile and the drug merits investigation in a phase 3 trial.
Journal ArticleDOI
Consensus statement from the International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain Injury : Consensus statement.
Peter J. Hutchinson,Angelos G. Kolias,Tamara Tajsic,Amos Olufemi Adeleye,Amos Olufemi Adeleye,Abenezer Tirsit Aklilu,Abenezer Tirsit Aklilu,Tedy Apriawan,Abdul Hafid Bajamal,Ernest J. Barthélemy,B Indira Devi,Dhananjaya I Bhat,Diederik Bulters,Randall M. Chesnut,Giuseppe Citerio,D. Jamie Cooper,D. Jamie Cooper,Marek Czosnyka,Idara Edem,Nasser M F El-Ghandour,Anthony Figaji,Kostas N. Fountas,Clare N. Gallagher,Gregory W.J. Hawryluk,Corrado Iaccarino,Mathew Joseph,Tariq Khan,Tsegazeab Laeke,Tsegazeab Laeke,Oleg V. Levchenko,Baiyun Liu,Weiming Liu,Andrew I R Maas,Geoffrey T. Manley,Paul N. Manson,Anna Teresa Mazzeo,David K. Menon,Daniel B. Michael,Susanne Muehlschlegel,David O. Okonkwo,Kee B. Park,Jeffrey V. Rosenfeld,Jeffrey V. Rosenfeld,Gail Rosseau,Andres M. Rubiano,Hamisi K. Shabani,Nino Stocchetti,Nino Stocchetti,Shelly D. Timmons,Ivan Timofeev,Chris Uff,Chris Uff,Jamie S. Ullman,Alex B. Valadka,Vicknes Waran,Adam J. Wells,Mark Wilson,Franco Servadei +57 more
TL;DR: The International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain Injury took place in Cambridge, UK, on the 28th and 29th September 2017 and presented the final consensus-based recommendations.
Journal ArticleDOI
Self-Fulfilling Prophecies Through Withdrawal of Care: Do They Exist in Traumatic Brain Injury, Too?
TL;DR: Factors associated with withdrawal of care in moderate-severe traumatic brain injury patients, and how WOC may affect short-term mortality and receipt of neurosurgery were examined, finding WOC was the most important predictor of in-hospital mortality.
Journal ArticleDOI
Medical Management of the Severe Traumatic Brain Injury Patient.
TL;DR: Prehospital and emergency department management of sTBI, as well as aspects of TBI management in the intensive care unit where advances have been made in the past decade are discussed.
Journal ArticleDOI
Dantrolene: Mechanisms of Neuroprotection and Possible Clinical Applications in the Neurointensive Care Unit
TL;DR: Dantrolene, an inhibitor of the ryanodine receptor, inhibits intracellular calcium release from the sarco-endoplasmic reticulum, which has potential applications for patients in the neurointensive care unit (NICU).